BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 11664810)

  • 1. Informed consent to participate in research: Part II.
    Levine RJ
    Bioethics Dig; 1977 Apr; 1(12):1-16. PubMed ID: 11664810
    [No Abstract]   [Full Text] [Related]  

  • 2. Protecting research subjects after consent: the case for the "research intermediary.
    Reiser SJ; Knudson P
    IRB; 1993; 15(2):10-1. PubMed ID: 11651567
    [No Abstract]   [Full Text] [Related]  

  • 3. Informed consent process and document is criticized in court.
    Maloney DM
    Hum Res Rep; 1994 Dec; 9(12):4-5. PubMed ID: 11654162
    [No Abstract]   [Full Text] [Related]  

  • 4. Research subject loses case against physician, IRB, and hospital.
    Maloney DM
    Hum Res Rep; 1995 Feb; 10(2):4-5. PubMed ID: 11654160
    [No Abstract]   [Full Text] [Related]  

  • 5. Annual review: observed deficiencies and suggested corrections.
    Adams MS; Conrad DA
    IRB; 1996; 18(6):1-4. PubMed ID: 11654743
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethics in neurobiological research with human subjects -- final reflections.
    Katz J
    Account Res; 1996; 4(3-4):277-83. PubMed ID: 11654523
    [No Abstract]   [Full Text] [Related]  

  • 7. Hospital failed on human research policy.
    Science; 1998 Nov; 282(5391):1035. PubMed ID: 11645114
    [No Abstract]   [Full Text] [Related]  

  • 8. Changing federal regulation of IRB's: the Commission's recommendations and the FDA's proposals.
    Levine RJ
    IRB; 1979 Mar; 1(1):1-3+. PubMed ID: 11662736
    [No Abstract]   [Full Text] [Related]  

  • 9. Informed consent process is deemed "legally and ethically invalid" by witness.
    Maloney DM
    Hum Res Rep; 1995 Jan; 10(1):4-5. PubMed ID: 11660008
    [No Abstract]   [Full Text] [Related]  

  • 10. IRBs and pharmaceutical company funding of research.
    Jellinek MS; Levine RJ
    IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
    [No Abstract]   [Full Text] [Related]  

  • 11. Human experimentation: the review process in practice.
    Cowan DH
    Case West Reserve Law Rev; 1975; 25(3):533-64. PubMed ID: 11661165
    [No Abstract]   [Full Text] [Related]  

  • 12. Proposed requirements for informed consent go beyond current federal regulations.
    Hum Res Rep; 1994 Jul; 9(7):1-3. PubMed ID: 11659879
    [No Abstract]   [Full Text] [Related]  

  • 13. The FDA's final regulations: IRBs and medical devices.
    Holder AR
    IRB; 1980; 2(6):1-4. PubMed ID: 11661803
    [No Abstract]   [Full Text] [Related]  

  • 14. Informed consent in psychiatric research.
    Roth LH; Appelbaum PS; Lidz CW; Benson P; Winslade WJ
    Rutgers Law Rev; 1987; 39(2-3):425-41. PubMed ID: 11659013
    [No Abstract]   [Full Text] [Related]  

  • 15. Federal agency's final rule says informed consent forms must be dated.
    Maloney DM
    Hum Res Rep; 1996 Dec; 11(12):1-2. PubMed ID: 11655034
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurobiological research involving human subjects: perspectives from the Office for Protection from Research Risks.
    Puglisi JT; Ellis GB
    Account Res; 1996; 4(3-4):261-5. PubMed ID: 11654521
    [No Abstract]   [Full Text] [Related]  

  • 17. The FDA's enforcement of IRBs and patient informed consent.
    Kelsey FO
    Food Drug Cosmet Law J; 1989 Jan; 44(1):13-20. PubMed ID: 11651627
    [No Abstract]   [Full Text] [Related]  

  • 18. Special informed consent requirements are included in protocol review procedures.
    Maloney DM
    Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
    [No Abstract]   [Full Text] [Related]  

  • 19. Power, advocacy, and informed consent forms.
    Smith ML
    J Calif Alliance Ment Ill; 1994; 5(1):25-7. PubMed ID: 11653311
    [No Abstract]   [Full Text] [Related]  

  • 20. Legal and financial encumbrances to clinical research.
    Sonnenreich MR
    Perspect Biol Med; 1980 Pt 2): S120-S149, Winter; 23(2):. PubMed ID: 11663072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.